Citizens Community Bancorp, Inc. (CZWI) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.27 per share a year ago.

Bank of Marin (BMRC) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.38 per share a year ago.

Quantum computing company IonQ (NYSE:IONQ) announced Monday that it has entered into a definitive agreement to acquire SkyWater Technology (NASDAQ:SKYT), a US-based semiconductor foundry, in a cash-and-stock transaction valued at about $1.8 billion. Under the terms of the deal, SkyWater shareholders will receive $35 per share, subject to a collar.

It seems like any stock sitting adjacent to OpenAI has been punished severely in the past couple of months.

SAN FRANCISCO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is notifying Ardent Health, Inc. (NYSE: ARDT) investors that a securities class action lawsuit has been filed against the company and certain of its executives following the company's disastrous Q3 2025 financial results. Hagens Berman is investigating the alleged claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves.

JPMorgan analyst Harlan Sur said Broadcom Inc's (NASDAQ: AVGO) long lead in custom artificial intelligence (AI) chips is helping its AI Application-Specific Integrated Circuit (ASIC) outlook accelerate into fiscal 2026 and fiscal 2027, with Alphabet Inc (NASDAQ: GOOGL) Google as the key driver.

Micron Technology (NASDAQ:MU) shares are down 2.3% to trade at $390.36 at last glance, following news that Samsung is preparing to supply Nvidia (NVDA) with next-generation HBM4memory chips as early as next month.

SAN FRANCISCO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- A securities class action lawsuit has been filed against BellRing Brands, Inc. (NYSE: BRBR) and certain of its executives. The lawsuit follows BellRing's disastrous May 6, 2025, Q2 2025 and August 4, 2025, Q3 2025 earnings reports, each of which drove the price of BellRing shares sharply lower.

Novo Nordisk A/S's restructuring costs are front-loaded in Q3, with DKK 1 billion in savings accruing to Q4 earnings, setting up a potential beat on low expectations. The FDA-approved Wegovy oral pill launched in January 2026 with 18,000+ prescriptions in its debut week, expanding the addressable market to approximately 85 million Americans. Catalent fill-finish site integration is expected to double U.S. supply chain capacity by mid-2026, supporting margin expansion and reducing manufacturing bottlenecks going forward.

RGTI is deepening partnerships across AI, academia and government to validate its quantum roadmap.

HIMS expands its tech-driven care platform with new diagnostics, AI tools and specialty treatments for personalized health.

Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.

POWL is riding strong utility and industrial demand, lifting revenues and backlog, though rising costs and tariff risks pose near-term challenges.

SAN FRANCISCO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- National shareholder rights firm Hagens Berman is notifying investors in Fermi Inc. (NASDAQ: FRMI) of the upcoming March 6, 2026, lead plaintiff deadline in a pending securities class action. Hagens Berman is investigating the alleged claims that Fermi IPO materials and subsequent disclosures misled investors regarding tenant demand and funding for its flagship "Project Matador" AI campus.

Opening Bid anchor Brooke DiPalma breaks down the latest market news for January 26, 2026. Gold is trading above $5,000 per ounce after momentarily hitting a new record high above $5,100; silver also hit a record milestone above $110.

Philadelphia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against BellRing Brands, Inc. (NYSE: BRBR) ("BellRing" or the "Company") on behalf of investors who purchased or otherwise acquired BellRing securities during the period of November 19, 2024 through August 4, 2025 (the "Class Period"). Investor Deadline: Investors who purchased BellRing securities during the Class Period may, no later than March 23, 2026, seek to be appointed as a lead plaintiff representative of the class.

INTC shares plummet 17% after Q4 earnings release as weak Q1 guidance rattled investors, pushing Intel-heavy ETFs into focus for diversified exposure.

CHKP rolls out an AI-driven exposure management strategy to close the remediation gap, automate responses and speed fixes as cyber threats intensify.

SAM depends on its innovation pipeline as demand shifts beyond beer, with new launches driving mix, margins and category participation.

Axsome's Auvelity delivered robust 2025 sales growth. A pending FDA decision in 2026 could unlock a broader market and drive sales further.